13D Filing: Elliott Associates, L.P. and Cormedix Inc. (CRMD)

The following constitutes Amendment No. 5 (“Amendment No. 5”) to the Schedule 13D filed by the undersigned (the “Schedule 13D”). This Amendment No. 5 amends the Schedule 13D as specifically set forth herein.

Item 4.

Purpose of Transaction.

Item 4 is hereby amended to add the following:

Based upon discussions between the Reporting Persons and the Issuer, Dr. Gary Gelbfish has been appointed as a Board Observer to the Issuer’s Board of Directors to attend meetings in a non-voting capacity.